Rep profile
Rep profile
Cathy Cutler
company
Muro Pharmaceutical Inc., an ASTA Medica Co.
Title
Professional Medical Representative
current home
Long Beach, CA
Territory: North Orange County and eastern Los Angeles.
Customers: Allergists, pulmonologists, primary care physicians and pediatricians.
Awards: National salesperson of the year, 1995; western region salesperson of the year, 1996; Impact award, 1994; and the president's club four periods in a row.
Sales techniques: "I individualize my selling techniques for each physician in order to adapt to the different office environments. I am enthusiastic about my products and always plan for the call by preparing a selling strategy aimed at that physician."
The five P's: "'Proper preparation prevents poor performance.' My mentor trained me with this rule and I follow it for every call. I believe in working smart and always prepare for each office visit."
On goals: "I write down all my short-term and long-term goals and the steps I need to take to achieve these goals. I consistently analyze and re-evaluate the goals I set for each call. One goal is to close every call. I want the physicians to prescribe my product, not just give samples of my product."
On style: "I build friendships with the office staff and want the physicians to look forward to my visit. I always have a positive attitude when I visit the offices. Sometimes I bring in funny cartoons about the medical industry or baked goods. This is a great way for the physician to remember me and my product(s)."
The top three qualities a rep needs to succeed: "Have a competitive drive and perseverance, be enthusiastic and maintain a strong work ethic."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.